COVID-19 vaccination and breast cancer surgery timing

There have been recent reports in the breast imaging literature of unilateral axillary lymphadenopathy following COVID-19 vaccination. It is unclear whether the reactive lymphadenopathy may impact the sentinel lymph node biopsy procedure. In this article, we provide guidelines regarding the timing o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Gary, Hota, Susy, Cil, Tulin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217777/
https://www.ncbi.nlm.nih.gov/pubmed/34156582
http://dx.doi.org/10.1007/s10549-021-06293-6
_version_ 1783710659146416128
author Ko, Gary
Hota, Susy
Cil, Tulin D.
author_facet Ko, Gary
Hota, Susy
Cil, Tulin D.
author_sort Ko, Gary
collection PubMed
description There have been recent reports in the breast imaging literature of unilateral axillary lymphadenopathy following COVID-19 vaccination. It is unclear whether the reactive lymphadenopathy may impact the sentinel lymph node biopsy procedure. In this article, we provide guidelines regarding the timing of the COVID-19 vaccine and breast cancer surgery which were formulated after a review of the available literature and in consultation with infectious disease specialists.
format Online
Article
Text
id pubmed-8217777
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-82177772021-06-23 COVID-19 vaccination and breast cancer surgery timing Ko, Gary Hota, Susy Cil, Tulin D. Breast Cancer Res Treat Letter to the Editor There have been recent reports in the breast imaging literature of unilateral axillary lymphadenopathy following COVID-19 vaccination. It is unclear whether the reactive lymphadenopathy may impact the sentinel lymph node biopsy procedure. In this article, we provide guidelines regarding the timing of the COVID-19 vaccine and breast cancer surgery which were formulated after a review of the available literature and in consultation with infectious disease specialists. Springer US 2021-06-22 2021 /pmc/articles/PMC8217777/ /pubmed/34156582 http://dx.doi.org/10.1007/s10549-021-06293-6 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editor
Ko, Gary
Hota, Susy
Cil, Tulin D.
COVID-19 vaccination and breast cancer surgery timing
title COVID-19 vaccination and breast cancer surgery timing
title_full COVID-19 vaccination and breast cancer surgery timing
title_fullStr COVID-19 vaccination and breast cancer surgery timing
title_full_unstemmed COVID-19 vaccination and breast cancer surgery timing
title_short COVID-19 vaccination and breast cancer surgery timing
title_sort covid-19 vaccination and breast cancer surgery timing
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217777/
https://www.ncbi.nlm.nih.gov/pubmed/34156582
http://dx.doi.org/10.1007/s10549-021-06293-6
work_keys_str_mv AT kogary covid19vaccinationandbreastcancersurgerytiming
AT hotasusy covid19vaccinationandbreastcancersurgerytiming
AT ciltulind covid19vaccinationandbreastcancersurgerytiming

Ejemplares similares